Press Releases

Usona Identifies Controlled Crystal Engineering Process for Large-Scale Synthesis of Psilocybin Polymorphs

February 7, 2022

Crystallographic Discoveries Bring New Clarity to Pharmaceutical Psilocybin Polymorph Characterization

December 20, 2021

Usona Institute Breaks Ground for Global Center in Psychedelic Science

August 3, 2021

Usona Institute Publishes Synthesis and Characterization of cGMP 5-MeO-DMT

December 8, 2020

Usona Institute Publishes Breakthrough Development in Scalable Psilocybin Synthesis

August 3, 2020

FDA grants Breakthrough Therapy Designation to Usona Institute's psilocybin program for major depressive disorder

November 22, 2019

Usona Institute PSIL201 Study Site Now Recruiting Patients with Depression

October 24, 2019

Usona Institute Clinical Trial of Psilocybin for Major Depressive Disorder Launching This Fall

September 5, 2019